Armonica Technologies is a MedTech company specializing in advanced long read sequencing platforms aimed at precision medicine. The company operates in the biotechnology sector, focusing on developing a novel DNA sequencing technology that uses single nucleotide spectroscopy to identify nucleotide and epigenetic information directly from native DNA, without the need for amplification or labeling. This technology addresses the limitations of current Next-Generation Sequencing (NGS) methods and offers significant advantages over other long-read sequencing technologies, such as pore-based techniques. Armonica's platform is designed to be elegant, inexpensive, and manufacturable, making it a viable solution for a wide range of applications in precision medicine. The company primarily serves researchers, healthcare providers, and pharmaceutical companies who require accurate and efficient DNA sequencing for various medical and scientific purposes. Armonica Technologies generates revenue through the sale of its sequencing platforms and related services. The company is headquartered in San Diego, CA, and continues to innovate in the field of DNA sequencing to meet the growing demands of the healthcare and biotechnology markets.

Keywords: DNA sequencing, precision medicine, biotechnology, single nucleotide spectroscopy, epigenetic information, MedTech, NGS, long-read technology, healthcare, San Diego.